1. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005; 352:2266–2267. PMID:
15930416.
Article
2. Levin MJ, Gershon AA, Dworkin RH, Brisson M, Stanberry L. Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol. 2010; 48(Suppl 1):S14–S19. PMID:
20510262.
Article
3. Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain. 2000; 87:121–129. PMID:
10924805.
Article
4. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010; 150:573–581. PMID:
20705215.
Article
5. Chen JY, Chu CC, So EC, Hsing CH, Hu ML. Treatment of postherpetic neuralgia with intravenous administration of vitamin C. Anesth Analg. 2006; 103:1616–1617. PMID:
17122283.
Article
6. Chen JY, Chang CY, Feng PH, Chu CC, So EC, Hu ML. Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain. 2009; 25:562–569. PMID:
19692796.
Article
7. Schencking M, Sandholzer H, Frese T. Intravenous administration of vitamin C in the treatment of herpetic neuralgia: two case reports. Med Sci Monit. 2010; 16:CS58–CS61. PMID:
20424557.
8. Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010; 182:1731–1736. PMID:
20921251.
Article
9. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain. 1996; 67:241–251. PMID:
8951917.
Article
10. Petersen KL, Rowbotham MC. Natural history of sensory function after herpes zoster. Pain. 2010; 150:83–92. PMID:
20452122.
Article
11. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003; 60:1274–1283. PMID:
12707429.
Article
12. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996; 63:760–765. PMID:
8615361.
Article
13. Besse JL, Gadeyne S, Galand-Desmé S, Lerat JL, Moyen B. Effect of vitamin C on prevention of complex regional pain syndrome type I in foot and ankle surgery. Foot Ankle Surg. 2009; 15:179–182. PMID:
19840748.
Article
14. Perez RS, Zollinger PE, Dijkstra PU, Thomassen-Hilgersom IL, Zuurmond WW, Rosenbrand KC, et al. Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol. 2010; 10:20. PMID:
20356382.
Article
15. Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010; 113:713–725. PMID:
20693883.
Article
16. Miclescu A, Gordh T. Nitric oxide and pain: 'Something old, something new'. Acta Anaesthesiol Scand. 2009; 53:1107–1120. PMID:
19702699.
Article
17. Chung JM. The role of reactive oxygen species (ROS) in persistent pain. Mol Interv. 2004; 4:248–250. PMID:
15471906.
Article
18. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000; 23:209–216. PMID:
10782126.
Article
19. Lonnrot K, Metsä-Ketelä T, Molnár G, Ahonen JP, Latvala M, Peltola J, et al. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic Biol Med. 1996; 21:211–217. PMID:
8818636.
Article